FDA grants ‘fast track designation’ to Tekmira to develop Ebola drug

Canadian pharmaceutical company, Tekmira Pharmaceuticals Corporation announced Wednesday that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of TKM-Ebola, an anti-Ebola More...